Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

Amazon launches its AI drug discovery platform

 April 15, 2026

Pharmaphorum

Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that combines in silico and wet-lab work in a single application.

OtherRead full story

Post navigation

Lilly’s new obesity pill linked to ‘serious’ safety signals, FDA requests more data →
← J&J sets the tone for Q1 earnings with strong oncology growth

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com